vs

Side-by-side financial comparison of PACS Group, Inc. (PACS) and Teradyne (TER). Click either name above to swap in a different company.

PACS Group, Inc. is the larger business by last-quarter revenue ($1.4B vs $1.3B, roughly 1.1× Teradyne). Teradyne runs the higher net margin — 31.1% vs 4.4%, a 26.7% gap on every dollar of revenue. On growth, Teradyne posted the faster year-over-year revenue change (87.0% vs 18.4%). Over the past eight quarters, Teradyne's revenue compounded faster (32.6% CAGR vs 20.5%).

Teradyne, Inc. is an American automatic test equipment (ATE) designer and manufacturer based in North Reading, Massachusetts. Its high-profile customers include Samsung, Qualcomm, Intel, Analog Devices, Texas Instruments and IBM.

PACS vs TER — Head-to-Head

Bigger by revenue
PACS
PACS
1.1× larger
PACS
$1.4B
$1.3B
TER
Growing faster (revenue YoY)
TER
TER
+68.6% gap
TER
87.0%
18.4%
PACS
Higher net margin
TER
TER
26.7% more per $
TER
31.1%
4.4%
PACS
Faster 2-yr revenue CAGR
TER
TER
Annualised
TER
32.6%
20.5%
PACS

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
PACS
PACS
TER
TER
Revenue
$1.4B
$1.3B
Net Profit
$59.7M
$398.9M
Gross Margin
60.9%
Operating Margin
7.0%
36.9%
Net Margin
4.4%
31.1%
Revenue YoY
18.4%
87.0%
Net Profit YoY
3022.5%
EPS (diluted)
$0.42
$2.53

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PACS
PACS
TER
TER
Q1 26
$1.3B
Q4 25
$1.4B
$1.1B
Q3 25
$1.3B
$769.2M
Q2 25
$1.3B
$651.8M
Q1 25
$1.3B
$685.7M
Q4 24
$1.1B
$752.9M
Q3 24
$1.0B
$737.3M
Q2 24
$981.4M
$729.9M
Net Profit
PACS
PACS
TER
TER
Q1 26
$398.9M
Q4 25
$59.7M
$257.2M
Q3 25
$52.4M
$119.6M
Q2 25
$51.0M
$78.4M
Q1 25
$28.5M
$98.9M
Q4 24
$1.9M
$146.3M
Q3 24
$15.6M
$145.6M
Q2 24
$-10.9M
$186.3M
Gross Margin
PACS
PACS
TER
TER
Q1 26
60.9%
Q4 25
57.2%
Q3 25
58.4%
Q2 25
57.2%
Q1 25
60.6%
Q4 24
59.4%
Q3 24
17.1%
59.2%
Q2 24
22.3%
58.3%
Operating Margin
PACS
PACS
TER
TER
Q1 26
36.9%
Q4 25
7.0%
27.1%
Q3 25
6.4%
18.9%
Q2 25
6.2%
13.9%
Q1 25
3.8%
17.6%
Q4 24
1.7%
20.4%
Q3 24
2.2%
20.6%
Q2 24
0.1%
28.8%
Net Margin
PACS
PACS
TER
TER
Q1 26
31.1%
Q4 25
4.4%
23.7%
Q3 25
3.9%
15.5%
Q2 25
3.9%
12.0%
Q1 25
2.2%
14.4%
Q4 24
0.2%
19.4%
Q3 24
1.5%
19.8%
Q2 24
-1.1%
25.5%
EPS (diluted)
PACS
PACS
TER
TER
Q1 26
$2.53
Q4 25
$0.42
$1.62
Q3 25
$0.32
$0.75
Q2 25
$0.31
$0.49
Q1 25
$0.17
$0.61
Q4 24
$-0.03
$0.89
Q3 24
$0.10
$0.89
Q2 24
$-0.07
$1.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PACS
PACS
TER
TER
Cash + ST InvestmentsLiquidity on hand
$197.0M
$241.9M
Total DebtLower is stronger
$353.2M
$0
Stockholders' EquityBook value
$946.8M
Total Assets
$5.6B
$4.4B
Debt / EquityLower = less leverage
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PACS
PACS
TER
TER
Q1 26
$241.9M
Q4 25
$197.0M
$293.8M
Q3 25
$355.7M
$272.7M
Q2 25
$294.2M
$339.3M
Q1 25
$287.5M
$475.6M
Q4 24
$157.7M
$553.4M
Q3 24
$49.5M
$510.0M
Q2 24
$73.4M
$421.9M
Total Debt
PACS
PACS
TER
TER
Q1 26
$0
Q4 25
$353.2M
Q3 25
Q2 25
Q1 25
Q4 24
$411.9M
Q3 24
Q2 24
Stockholders' Equity
PACS
PACS
TER
TER
Q1 26
Q4 25
$946.8M
$2.8B
Q3 25
$871.3M
$2.7B
Q2 25
$806.8M
$2.8B
Q1 25
$750.2M
$2.8B
Q4 24
$709.6M
$2.8B
Q3 24
$660.0M
$2.9B
Q2 24
$572.1M
$2.7B
Total Assets
PACS
PACS
TER
TER
Q1 26
$4.4B
Q4 25
$5.6B
$4.2B
Q3 25
$5.6B
$4.0B
Q2 25
$5.5B
$3.8B
Q1 25
$5.5B
$3.7B
Q4 24
$5.2B
$3.7B
Q3 24
$4.5B
$3.8B
Q2 24
$3.9B
$3.6B
Debt / Equity
PACS
PACS
TER
TER
Q1 26
Q4 25
0.37×
Q3 25
Q2 25
Q1 25
Q4 24
0.58×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PACS
PACS
TER
TER
Operating Cash FlowLast quarter
$-3.4M
$265.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
-0.06×
0.66×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PACS
PACS
TER
TER
Q1 26
$265.1M
Q4 25
$-3.4M
$281.6M
Q3 25
$204.8M
$49.0M
Q2 25
$52.6M
$182.1M
Q1 25
$150.2M
$161.6M
Q4 24
$64.6M
$282.6M
Q3 24
$209.2M
$166.3M
Q2 24
$34.8M
$216.1M
Free Cash Flow
PACS
PACS
TER
TER
Q1 26
Q4 25
$218.8M
Q3 25
$2.4M
Q2 25
$131.7M
Q1 25
$97.6M
Q4 24
$225.2M
Q3 24
$114.4M
Q2 24
$171.2M
FCF Margin
PACS
PACS
TER
TER
Q1 26
Q4 25
20.2%
Q3 25
0.3%
Q2 25
20.2%
Q1 25
14.2%
Q4 24
29.9%
Q3 24
15.5%
Q2 24
23.5%
Capex Intensity
PACS
PACS
TER
TER
Q1 26
Q4 25
5.8%
Q3 25
6.1%
Q2 25
7.7%
Q1 25
9.3%
Q4 24
7.6%
Q3 24
7.0%
Q2 24
6.1%
Cash Conversion
PACS
PACS
TER
TER
Q1 26
0.66×
Q4 25
-0.06×
1.09×
Q3 25
3.91×
0.41×
Q2 25
1.03×
2.32×
Q1 25
5.28×
1.63×
Q4 24
33.78×
1.93×
Q3 24
13.39×
1.14×
Q2 24
1.16×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons